FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, specifically to a method of extracting a purified thrombin concentrate. Method for preparing thrombin concentrate, free from viruses comprising cryofractionation of fresh frozen human blood plasma, prothrombin complex separation on an anion exchange sorbent DEAE Sepharose Fast Flow, activation of prothrombin solution of CaCl2 prothrombin complex composed of thrombin to yield viral inactivation by solvent-detergent and purified thrombin prepared cation exchange sorbent Fractogel EMD-SO3 followed by sterile filtration and lyophilisation.
EFFECT: described method increases purity and output of end product.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING VIRUS-SAFE COMPLETE PROTHROMBIN COMPLEX | 2014 |
|
RU2559576C1 |
METHOD FOR OBTAINING A LIOPHILIZED PREPARATION OF AN ACTIVATED PROTROMBIN COMPLEX HAVING VIII-SHUNTING ACTIVITY FACTOR | 2017 |
|
RU2648517C1 |
METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
SOLUTION FOR CORRECTION OF PRIMARY HOMEOSTASIS DISORDER WITH PLASMA-SUBSTITUTING SOLUTIONS OF NOVEL COMPOSITION | 2005 |
|
RU2300385C1 |
METHOD OF PREPARING FACTOR VIII PREPARATION | 2004 |
|
RU2253475C1 |
METHOD OF PREPARING OF CONCENTRATE OF FACTOR VIII AND VON VILLEBRAND FACTOR | 1990 |
|
RU2025129C1 |
PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
METHOD FOR CHROMATOGRAPHIC EXTRACTION AND PURIFICATION OF IMMUNOGLOBULINS | 2018 |
|
RU2694620C1 |
METHOD OF PURIFYING THERAPEUTIC PROTEINS | 2013 |
|
RU2685956C2 |
METHOD FOR PREPARING HUMAN C-1 ESTERASE INHIBITOR AMD PRODUCT FOR USING IN MEDICINE | 2004 |
|
RU2256464C1 |
Authors
Dates
2016-05-10—Published
2014-06-11—Filed